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Background: Human papillomavirus type-16 (HPV-16) E2 protein acts as a transcriptional modulator and plays a key
role in regulating many biological responses. The purpose of this study was to investigate the relationship between
HPV-16 E2, the receptor for the globular heads of human C1q (gC1qR) gene expression, mitochondrial dysfunction
and apoptosis regulation in human cervical squamous carcinoma cells (C33a and SiHa).
Methods: HPV-16 E2 and gC1qR expression was examined using real-time PCR and western blot analysis. Apoptosis
in C33a and SiHa cells was assessed by flow cytometry. Mitochondrial function was detected via ROS generation,
the amount of cytosolic Ca2+, and changes in the mitochondrial membrane potential (Δψm).
Results: The expression of the HPV-16 E2 and gC1qR gene significantly decreased in human cervical squamous
carcinoma samples relative to the non-cancerous cervix samples. C33a and SiHa cells that were transfected with a
vector encoding HPV-16 E2 displayed significantly increased gC1qR gene expression and mitochondrial dysfunction
as well as an up-regulation of cellular apoptosis, which was abrogated by the addition of gC1qR small-interfering
RNA (siRNA).
Conclusions: These data support a mechanism whereby gC1qR plays an important role in HPV-16 E2-induced
human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathway.
Keywords: Human papillomavirus type 16 (HPV-16) E2, Receptor for the globular heads of the human C1q (gC1qR),
Mitochondrial dysfunction, Apoptosis, Human cervical squamous carcinoma cellsBackground
Cervical cancer is the second most frequent malignancy
in women and is responsible for substantial number of
morbidities and mortalities throughout the word [1].
Molecular and epidemiological studies have shown that
infection with a high-risk human papillomavirus (HPV)
type is a major factor in the development of cervical
cancer and is responsible for nearly all cases of cervical
cancer [2]. Of the over 100 HPV types known thus far,
HPV-16 is the most common high-risk virus and causes* Correspondence: njgpq@163.com; gaolingjuan@njmu.edu.cn
†Equal contributors
3State Key Laboratory of Reproductive Medicine, Department of Clinical
Laboratory, Nanjing Maternity and Child Health Care Hospital Affiliated to
Nanjing Medical University, Nanjing 210004, China
Full list of author information is available at the end of the article
© 2014 Chen et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.more than 50% of all cases of cervical carcinoma [3].
During carcinogenesis, HPV-16 DNA integrates into the
host cell genome, resulting in a loss of expression of the
regulatory gene E2, which is relatively conserved among
papillomaviruses [4]. In addition to being a transcrip-
tional regulator, the E2 protein negatively regulates the
HPV viral oncogenes E6 and E7 in benign lesions [5]. E2
proteins from high-risk HPV have been proven to affect
cellular processes such as anti-proliferation, apoptosis,
regulation of the viral life cycle, and gene expression
[6,7]. Previous studies have shown a direct relationship
between HPV E2 gene expression and mitochondrial
dysfunction in apoptosis in cervical cancer cells [8].
The main function of mitochondria is to produce en-
ergy by synthesising ATP. Reactive oxygen species (ROS)td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the pathological level and also plays an important role
in redox signalling from the organelle to the rest of the
cell [9]. Studies have demonstrated that the high-risk
HPV-16 E2 protein can induce mitochondrial dysfunc-
tion by regulating protein expression and the localisa-
tion of proteins to mitochondrial membranes [10]. The
receptor for the globular head of C1q, gC1qR, was ini-
tially identified as a protein within the mitochondrial
matrix [11] that could mediate many biological re-
sponses, including growth perturbations, morphological
abnormalities and the initiation of apoptosis [12]. This
study aimed to comprehensively identify the effect of
the gC1qR gene on HPV-16 E2-induced apoptosis of
cells and to investigate whether the gC1qR-induced
biological changes acted through a mitochondria-




The human cervical squamous carcinoma cell lines C33a
(HPV-16 negative) and SiHa (HPV-16 positive) were
purchased from Hangzhou Hibio Bio-tech Co., Ltd
(Hangzhou, Zhejiang, China). Dulbecco’s Modified Eagle’s
Medium (DMEM) powder, penicillin and streptomycin
were purchased from Invitrogen/Gibco (Grand Island, NY,
USA). The Phototope-HRP Western Blot Detection Sys-
tem, including an anti-mouse IgG, an HRP-linked anti-
body, a biotinylated protein ladder, 20X LumiGLO Reagent
and 20X peroxide, was purchased from Cell Signalling
Technology (Beverly, MA, USA). Lipofectamine 2000,
was purchased from Invitrogen (Carlsbad, CA, USA).
2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA) was
obtained from Molecular Probes. The Annexin V-FITC/
Propidium Iodide (PI) Flow Cytometry Assay Kit was pur-
chased from Invitrogen (Carlsbad, CA, USA). Antibodies
targeting HPV-16 E2, gC1qR, and actin were purchased
from Santa Cruz (Santa Cruz, CA, USA) and Cell
Signalling Technology. The pcDNA-HPV-16 E2 and
pcDNA-HPV-16 E2 mutant (mut) plasmids were kindly
supplied by Hangzhou Hibio Bio-tech Co., Ltd. gC1qR
small-interfering RNA (siRNA) and negative siRNA (siRNA
directed toward an unrelated gene as a negative control)
were synthesised by Wuhan Genesil Biotechnology Co.,
Ltd (Wuhan, China). Cell culture supplies were pur-
chased from Life Technologies (Gaithersburg, MD,
USA). Unless otherwise specified, all of the other re-
agents were of analytical grade.
Tissue procurement and preparation
Between October 2009 and January 2012, we recruited
women who underwent radical hysterectomies due to
cervical carcinoma at Nanjing Maternity and ChildHealth Care Hospital. This study was approved by the
Ethical Committee of the Chinese Academy of Sciences
and the Nanjing Maternity and Child Health Care
Hospital in Nanjing. All of the study participants gave
informed consent for the collection of the tissues and
blood samples. Human cervical cancer specimens were
obtained from 30 HPV-16-positive patients (median age
of 45 years, age range between 22–59 years), which were
studied along with a control group (median age of
43 years, age range between 21-54 years). Some cervix
tissues from non-cervical cancer patients who have had
a hysterectomy for hysteromyoma or adenomyosis etc
were collected, the other from patients who have had a
tissue biopsy for non cancer diagnoses. From those tis-
sues, thirty cases from the patients (HPV-16 is positive,
and the HPV typing was detected using gene chip tech-
nique in this study) were chosen as the control group,
which pathological diagnosis was mild cervicitis or have
no obvious pathological changes. The human cervical
squamous cell carcinoma tissues and non-cancerous cer-
vix tissues were all reviewed by a pathologist and histo-
logically. The infection of other sexually transmitted
pathogens including CT, NG, GV, MG, TV, MH, and
HSV-2 was detected by routine clinical microbiology
methods before the HPV analysis.
Cell culture
The human cervical carcinoma cell lines C33a and SiHa
were cultured in DMEM medium containing 10% foetal
bovine serum, 1% nonessential amino acids, 2 mM glu-
tamine, and antibiotics (100 units/ml penicillin and
streptomycin). The cells were maintained in a humidi-
fied 5% CO2 incubator at 37°C.
Cloning and transfection of the HPV-16 E2 plasmids
The full-length HPV-16 E2 open reading frame (ORF)
was constructed in-frame into the pcDNA 3.1 expression
plasmid (Invitrogen, Carlsbad, CA) by PCR amplification
using the BamHI and EcoRI restriction sites according
to the pBR322 reference clone. Primer-F (5′-GAT GGA
GAC TCT TTG CCA ACG-3′) and Primer-R (5′-TCA
TAT AGA CAT AAA TCC AGT AGA C-3′) were used
to clone the HPV-16 E2. The mutant HPV-16 E2 plas-
mid was created by PCR mutagenesis using the Primer-F
(5′-GAT GGA GAC TCT TTG CCA ACG-3′) and mu-
tant Primer-R (5′-TCC CAT TCT CTG GCC TTG TAA
ATA GCA CA TGC TAG-3′), where the mutated co-
dons are denoted in bold and italic. The HPV-16 E2 mu-
tant reduced DNA replication activity and transactivation
regulation [13]. The resulting pcDNA-HPV-16 E2 vector
and mutant HPV-16 E2 vector were then transfected into
C33a and SiHa cells, respectively. Twenty-four hours after
plating, the cells were serum starved in RPMI-1640
medium containing 0.5% FBS for an additional 24 h until
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pcDNA-HPV-16 E2 was transfected into the cells
(90% confluent) at passage numbers 6, 9 and 12 using
Lipofectamine™ reagent (Life Technologies, Inc.) ac-
cording to the manufacturer’s protocol. Reporter gene
levels were normalised to the amount of total protein,
and each experiment was independently performed
three to five times.
gC1qR siRNA-expressing plasmid construction
To silence the objective genes, the siRNA target gene
sequence was designed to be homologous to nucleo-
tides 408-426 of the human gC1qR mRNA. The for-
ward siRNA sequence was 5′-AAC AAC AGC AUC
CCA CCA ACA UU-3′. The 5′ end oligonucleotides
contained BamHI and HindIII restriction site over-
hangs. The gC1qR siRNA-expressing plasmid was con-
structed using pGenesil-1 as the vector backbone. The
siRNA was synthesised, annealed and ligated into the
BamHI and HindIII restriction sites in the linearised
pGenesil-1 expression vector. At the same time, a vec-
tor containing the siRNA for an unrelated gene was
used as a negative control.
Scanning and transmission electron microscopy
Biopsies were taken immediately after surgery. Tumour
specimens were obtained by cutting longitudinal sec-
tions of 3-5-mm maximum thickness, which were
immersed in phosphate-buffered 2.5% glutaraldehyde for
2 h. Following an overnight washing with 0.1 M sodium
phosphate buffer, the tissue blocks were post-fixed in 1%
OsO4 in a 0.1 M phosphate buffer (pH 7.4) for 1 h,
stained with 1% uranyl acetate, and then dehydrated in
an acetone gradient. For transmission electron micros-
copy, ultrathin (60-70 nm) sections were stained with
uranyl acetate and lead citrate. The cell morphology was
examined at 3700X and 12500X magnification and
photographed using a JEOL JEM-2000EX transmission
electron microscope (Tokyo, Japan).
Western blot analysis
Following various treatments for 48 h, cells were har-
vested in ice-cold PBS, pelleted at 15,000 rpm for 5 min,
and then incubated in lysis buffer containing 50 mM
Tris-HCl (pH 7.4), 0.5% NP-40, 150 mM NaCl, 50 mM
NaF, 1 mM Na3VO4, 1% Triton X-100, 1 mM EDTA,
1 mM PMSF, 10% glycerol, and protease inhibitor cock-
tail on ice for 30 min. The supernatants were centri-
fuged for 20 min at 13,000 rpm at 4°C. The protein was
estimated using the Bradford reagent. Equal amounts of
protein were loaded and separated on a 10-15% SDS-
polyacrylamide gel and then transferred onto a PVDF
membrane. The membranes were blocked for 1 h in 5%
non-fat milk in PBST (PBS containing 0.05% Tween 20)and then incubated with the appropriate primary anti-
bodies against HPV-16 E2 or actin at a 1:500 dilution.
The membrane was washed in PBST and incubated with
the secondary IgG HRP-conjugated antibody at a 1:500
dilution. The protein bands were visualised using the en-
hanced chemiluminescence (ECL) Western Detection
System, and the densitometry analysis was performed on
the scanned immunoblot images using the Image J gel
analysis tool.
Assay of intracellular ROS
ROS production was measured using the cell-permeable
probe H2DCFDA, which preferentially measures perox-
ides. Briefly, C33a and SiHa cells were grown on cover
slips and incubated with 10 μM H2DCFDA under vari-
ous conditions for 15 min in the dark. The cells were
then lysed with RIPA buffer in ice-cold conditions [14].
H2DCFDA fluorescence was detected using fluorescence
microscopy at an excitation wavelength of 488 nm and
an emission wavelength of 530 nm. A spectrofluorome-
ter with a slit width of 5 nm was used to quantify the
fluorescence levels of the supernatants. The experiments
were repeated at least 10 times. The results were deter-
mined according to the increase in fluorescence intensity
with respect to normoxic untreated controls by subtract-
ing the basal fluorescence levels.
Measurement of the intracellular Ca2+ concentration
([Ca2+]i)
Fluo-4 AM fluorescence was used to quantify the intra-
cellular Ca2+ levels. C33a and SiHa cells were treated
under various conditions at the indicated times and then
washed with ice-cold PBS. The cells were resuspended
in 1 mL of PBS and incubated with 5 mL of 1 mM Fluo-
4 AM for 1 h. The fluorescence intensity was detected
using a Beckman Coulter Paradigm™ Detection Plat-
form at an excitation wavelength of 485 nm and an
emission wavelength of 530 nm to determine the intra-
cellular Ca2+ concentrations. Fluorometric measure-
ments were performed in 10 different sets and expressed
as the fold increase in fluorescence per microgram of
protein compared with the control group.
Measurement of the mitochondrial membrane potential
(Δψm)
The loss of mitochondrial membrane potential (Δψm) was
measured in C33a and SiHa cells after treatment under
varying conditions at different time intervals using the
fluorescent cationic dye JC-1, which is a mitochondria-
specific fluorescent dye [15]. The dye accumulates in
mitochondria with increasing Δψm under monomeric
conditions and can be detected at an excitation wave-
length of 485 nm and an emission wavelength of 530 nm.
C33a and SiHa cells that had undergone the various
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60 h of growth and incubated with 10 μM JC-1 at 37°C.
Then, the C33a and SiHa cells were resuspended in
medium containing 10% serum, and the fluorescence
levels were measured at the two different wavelengths.
The data are representative of 10 individual experiments.
Detection of apoptotic cells
Apoptosis measurements were performed using Annexin
V-FITC/propidium iodide staining with flow cytometry
analysis. After different treatments at the indicated
times, C33a and SiHa cells were washed and resus-
pended in binding buffer (2.5 mM CaCl2, 10 mM
HEPES, pH 7.4, and 140 mM NaCl) before being trans-
ferred to a 5-mL tube. The cells were incubated in the
dark with 5 μL each of Annexin V-FITC and propidium
iodide for 15 min. The binding buffer was then added
to each tube, and the samples were analysed using a
Beckman Coulter Epics XL flow cytometer. The normal
cells were found in the Q1_LL region, and the early and
late apoptotic cells were distributed in the Q1_LR and
Q1_UR regions, respectively. The necrotic cells were lo-
cated in the Q1_UL region.
Statistical analysis
Unless otherwise indicated, the results represent the
mean ± standard deviation (SD). Differences between the
various datasets were tested for significance using Stu-
dent’s t-test, and p-values less than 0.05 were considered
significant (*p < 0.05; **p < 0.01; #p > 0.05).
Results
The expression of the HPV-16 E2 and gC1qR gene in
human cervical tissue
To investigate the relationship between the expression
of HPV-16 E2, gC1qR and human cervical squamous cell
carcinoma, HPV-16 E2 and gC1qR expression levels
were analysed in 30 cases of human cervical squamous
cell carcinoma and 30 cases of non-cancerous cervix tis-
sues. The HPV-16 E2 protein expression was analysed
by western blot analysis (Figure 1A). The results showed
that the expression levels of HPV-16 E2 protein were
significantly decreased in human cervical squamous cell
carcinoma tissues (T) compared with non-cancerous
cervix tissues (N). Meanwhile, our results further ana-
lyzed the gC1qR expression by immunohistochemistry,
real-time PCR and western blot analysis in human cer-
vical tissues. As is shown in Figure 1B-C, the gC1qR
expression significantly decreased in human cervical
squamous cell carcinoma tissue (T) when compared
with non-cancerous cervix tissues (N). These findings
suggested that HPV-16 E2 and gC1qR gene might play a
negative role in the survival of human cervical squamous
cell carcinomas.Forced expression of HPV-16 E2 induces apoptosis in
C33a and SiHa cells
To determine if the accumulation of HPV-16 E2 could
trigger apoptotic death, C33a and SiHa cells were
double-stained with Annexin V and PI and assessed by
flow cytometry following treatment with the empty vec-
tor, the HPV-16 E2 vector, or the HPV-16 E2 mutant
vector for 48 h. The early and late apoptotic cells were
distributed in the Q1_LR and Q1_UR regions, respect-
ively. The necrotic cells were located in the Q1_UL re-
gion. Figure 2A shows that the accumulation of the
HPV-16 E2 protein increased the number of C33a and
SiHa cells in the Q1_LR and Q1_UR regions in the
HPV-16 E2-transfected group. In contrast, there was no
change in the Q1_LR and Q1_UR regions of in the
empty vector or HPV-16 E2 mutant group compared
with the unmodified media group (control). The number
of cells in the Q1_LR and Q1_UR regions was notably
decreased in the cells transfected with the HPV-16 E2
mutant vector than when the HPV-16 E2 vector was
used. Visualisation of the HPV-16 E2 vector-transfected
cells at 48 h with an electron microscope (Figure 2B)
showed characteristic pathological subcellular changes
early on during the chromatin-condensation phase. These
changes included electron-dense nuclear material that was
aggregated peripherally under the nuclear membrane and
apoptosis bodies consisting of the cytoplasm with tightly
packed organelles. However, in the plain medium (control)
group, empty vector group, and HPV-16 E2 mutant vector
group, the morphology of the C33a and SiHa cells showed
no obvious apoptotic features.
The effect of gC1qR on HPV-16 E2-induced mitochondrial
dysfunction in C33a and SiHa cells
In previous experiments, our results revealed that the
forced expression of gC1qR induced mitochondrial dys-
function (including the production of ROS, cellular calcium
ion influx, and decrease of mitochondrial membrane poten-
tial) in cervical squamous carcinoma cell lines (Additional
file 1: Figure S1), these findings suggested that the gC1qR
play a negative role in the survival of cervical cancer
cells. To more completely understand the role of gC1qR
on HPV 16 E2-induced mitochondrial dysfunction and
apoptosis in cervical squamous carcinoma cell lines.
Firstly, the HPV 16 E2-induced gC1qR expression levels
were measured via real-time PCR and western blot analysis
(Additional file 2: Figure S2). This finding suggests that
HPV 16 E2 could induce the expression of gC1qR gene.
Secondly, C33a and SiHa cells were treated with plain
medium (control), negative siRNA vector and gC1qR
siRNA vector for 48 h. The expression of gC1qR was de-
tected to observe the silence of gC1qR gene (Additional
file 3: Figure S3). Lastly, C33a and SiHa cells were
treated with plain medium, HPV 16 E2 vector, HPV 16
Figure 1 The level of HPV-16 E2 and gC1qR protein in human cervical tissue. A: Relative HPV-16 E2 protein levels are shown between human
cervical squamous cell carcinoma tissues (T) and non-cancerous cervix tissues from patients who have had a hysterectomy for hysteromyoma or
adenomyosis etc (N). The expression of the HPV-16 E2 protein was measured using western blot analysis. The graph shows the relative HPV-16 E2
protein levels, which were quantified and normalised to β-actin. The results shown are the mean ± SD of 30 independent experiments (n = 30), each
conducted in triplicate. Student’s t-test: T versus N. **p < 0.01. B: The gC1qR levels in human cervical tissue. The results of immunohistochemical
staining. The positive results for the gC1qR antigen in human cervical tissues by immunohistochemistry (200X). a: Staining of the monoclonal anti-gC1qR
antibody in human cervical squamous cell carcinoma tissues. b: Staining of the monoclonal anti-gC1qR antibody in non-cancerous cervix tissues.
C: Relative gC1qR expression levels are shown between human cervical squamous cell carcinoma tissues (T) and non-cancerous cervix tissues
(N). a: The mRNA expression level of gC1qR was analysed by real-time PCR. b: The expression of the gC1qR protein was measured using west-
ern blot analysis. The graph displays the relative gC1qR protein levels normalised to β-actin. The results shown are the mean ± SD of 30 independ-
ent experiments (n = 30), each conducted in triplicate. Student’s t-test: N versus T. ***p < 0.001.
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siRNA vector for the indicated time periods. The expres-
sion of gC1qR was detected again (Additional file 4:
Figure S4), these dada indicated that gC1qR siRNA
could effectively silence the target gC1qR gene.
In subsequent experiments, cells were treated with ei-
ther plain medium, the HPV-16 E2 vector, the HPV-16
E2 + gC1qR siRNA vector, or the HPV-16 E2 + negative
siRNA vector for the indicated time periods. High-
magnification photomicrographs (12500X) taken with an
electron microscope showed severe pathological changes
in the mitochondrial morphology (Figure 3A), including
mitochondrial swelling and vesicular formation in the
C33a and SiHa cells transfected with either the HPV-16E2 vector or the HPV-16 E2 + negative siRNA vector. In
contrast, no obvious changes in the mitochondrial
morphology were seen in the cells treated with the plain
medium (control) or transfected with the HPV-16 E2 +
gC1qR siRNA vector.
Mitochondrial function was assessed by determining
changes in ROS generation, cytosolic Ca2+ levels, and
relative Δψm values. ROS generation was determined
using H2DCFDA fluorescence and quantified by flow
cytometry analysis (Figure 3B). The data showed that
ROS levels in the cells treated with either HPV-16 E2
or HPV-16 E2 + negative siRNA vector were signifi-
cantly increased compared to the control cells. In con-
trast, a slight change in ROS production was found in
Figure 2 Effects of HPV-16 E2 on apoptosis in C33a and SiHa cells. A: The apoptotic death of cells. C33a and SiHa cells were transfected with
the empty vector, the HPV-16 E2 vector, or the HPV-16 E2 mutant vector. At 48 h post-transfection, apoptosis was assessed by flow cytometry analysis
to detect the subG1 populations. **p < 0.01, ***p < 0.001, #p > 0.05 versus the plain medium group (control); ▲▲p < 0.01, ▲▲▲p < 0.001 versus the
empty vector group; △△p < 0.01, △△△p < 0.001 versus the HPV-16 E2 group. B: The morphology of the C33a and SiHa cells observed with an electron
microscope. No morphologic changes were observed in cells treated with plain medium (control), empty vector, or HPV-16 E2 mutant vector (3700X).
Apoptotic bodies were observed in HPV-16 E2 vector-transfected cells (3700X).
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tor compared with plain medium alone (control). The
ROS levels were notably decreased in cells transfected
with the HPV-16 E2 + gC1qR siRNA vector when com-
pared with cells only transfected with the HPV-16 E2
vector. There is an obvious difference between cells
transfected with the HPV-16 E2 + gC1qR siRNA vector
and cells transfected with the HPV-16 E2 + negative
siRNA vector.
Cytosolic Ca2+ levels were determined using a fluores-
cent ELISA reader (Figure 3C), and the results revealed
the [Ca2+]i concentration in the HPV-16 E2 vector cells
and the HPV- 16 E2 + negative siRNA vector cells was
increased compared with the plain medium-treated
C33a and SiHa cells. The cells transfected with the
HPV-16 E2 + gC1qR siRNA vector showed no changes
compared with the plain medium group. However, the
[Ca2+]i concentration in the HPV-16 E2 + gC1qR siRNA
vector cells was notably lower than that in the HPV-16
E2 vector cells. There was an obvious difference between
the HPV-16 E2 + gC1qR siRNA vector group and the
HPV-16 E2 + negative siRNA vector group after the ini-
tial manipulation.
The changes in relative Δψm values in differently treated
C33a and SiHa cells was also explored (Figure 3D). We
used the JC-1 dye to monitor the estimated Δψm using
the 590: 527 nm emission ratio at the specific time points.
The Δψm value in the HPV-16 E2 vector group and the
HPV-16 E2 + negative siRNA vector group decreased
when compared to the plain medium group. There was no
difference in the Δψm in the C33a and SiHa cells between
the HPV-16 E2 + gC1qR siRNA vector group and plainmedium group after the initial manipulation. In contrast,
the Δψm values were notably increased in the HPV-16
E2 + gC1qR siRNA vector group compared with the HPV-
16 E2 vector alone group. Interestingly, transfection of
HPV-16 E2 + negative siRNA vector group significantly
decreased the value of Δψm compared with the HPV-16
E2 + gC1qR siRNA vector group.
The effect of gC1qR on HPV-16 E2-induced apoptosis of
C33a and SiHa cells
To evaluate whether silencing the gC1qR gene could re-
verse HPV-16 E2-induced C33a and SiHa cell apoptosis,
cells were treated with either plain medium (control), the
HPV-16 E2 vector, the HPV-16 E2 + gC1qR siRNA vector,
or the HPV-16 E2 + negative siRNA vector for the indi-
cated time periods. Cells were double-stained with
Annexin V and PI (Figure 4). The early and late apoptotic
cells were distributed in the Q1_LR and Q1_UR regions,
respectively. The necrotic cells were located in the Q1_UL
region. Figure 4 shows that cells treated with the HPV-16
E2 vector and the HPV-16 E2 + negative siRNA vector re-
sulted in an increase in the number of cells in the Q1_LR
and Q1_UR regions compared with plain medium (con-
trol) group. However, there was no difference between the
HPV-16 E2 + gC1qR siRNA vector group and the plain
medium group (p > 0.05). The Q1_LR and Q1_UR regions
in the HPV-16 E2 + gC1qR siRNA vector-treated C33a
and SiHa cells were diminished compared with the HPV-
16 E2 vector group (p < 0.001). Treatment of the HPV-16
E2 + negative siRNA vector group significantly increased
the apoptotic cells compared with the HPV-16 E2 +
gC1qR siRNA vector group.
Figure 3 The effect of gC1qR on HPV-16 E2-induced mitochondrial function. A: The mitochondrial morphology was observed using electron
microscopy. Mitochondrial swelling and vesicular formation were observed in cells transfected with HPV-16 E2 vector or HPV-16 E2 + negative siRNA
vector (12500X). B: Constitutive expression of HPV-16 E2 following transfection with gC1qR siRNA or negative siRNA induced the production of ROS.
ROS generation was quantified by treatment with H2DCFDA for 30 min followed by fluorescence microscopy. **p < 0.01,
#p > 0.05 versus plain
medium group (control); ▲▲p < 0.01 versus HPV-16 E2 vector group; △△p < 0.01 versus the HPV-16 E2 + gC1qR siRNA vector group. C: Constitutive
expression of HPV-16 E2 induced cellular calcium ion influx in the C33a and SiHa cells. **p < 0.01, ***p < 0.001, #p > 0.05 versus plain medium
group (control); ▲▲p < 0.01, ▲▲▲p < 0.001 versus the HPV-16 E2 vector group; △△p < 0.01, △△△p < 0.001 versus the HPV-16 E2 + gC1qR siRNA
group. D: The mitochondrial membrane potential was measured. The relative Δψm value was detected by monitoring the fluorescence of JC-1
(590: 527 nm fluorescence ratio). **p < 0.01, *p < 0.05, #p > 0.05 versus plain medium group (control); ▲▲p < 0.01, ▲p < 0.05 versus the HPV-16
E2 vector group; △△p < 0.01, △p < 0.05 versus the HPV-16 E2 + gC1qR siRNA group.
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The results of this study show that over-expression of
HPV-16 E2 is associated with apoptosis of human cer-
vical squamous carcinoma cells. Our study has further
confirmed that over-expression of HPV-16 E2 could
regulate the expression of the gC1qR gene, which in-
duces mitochondrial dysfunction. These findings consti-
tute the first evidence that gC1qR is a target during
HPV-16 E2-induced apoptosis in human cervical squa-
mous carcinoma cells.
Experimental evidence has demonstrated that the pri-
mary host defence mechanism against viral infection is
to target apoptotic proteins, which, when released from
the mitochondria, regulate cellular responses includingthe promotion of cell proliferation or induction of cell
death [14]. For example, high-risk HPV-16 E6 was re-
ported to maintain mitochondrial morphology and in-
tegrity while inhibiting the release of the pro-apoptotic
factor cytochrome c, a potent catalyst of apoptosis [15].
Others studies also demonstrated that apoptosis is trig-
gered by over-expression of HPV-16 E2 by enhancing
the expression of pro-apoptotic Bax, inhibiting the ex-
pression of anti-apoptotic Bcl xl, releasing cytochrome c
from the mitochondria, and activating caspases-9 and -3
[16]. Interestingly, only high-risk HPV E2 proteins, such
as the six regulatory molecules (E1, E2, E4, E5, E6, and
E7) encoded by the HPV-16 genome, seem to be effect-
ive in modulating mitochondrial metabolism [17]. E2
Figure 4 The effect of gC1qR on HPV-16 E2-induced apoptotic death of cells. C33a and SiHa cells (2 × 106) were treated with plain medium,
HPV-16 E2 vector, HPV-16 E2 vector + gC1qR siRNA vector, or HPV-16 E2 vector + negative siRNA vector. At 48 h post-transfection, the cells were
subjected to flow cytometry analysis to detect the levels of apoptosis. The data represent the means ± SD. These data are representative of three
independent experiments. ***p < 0.001, #p > 0.05 versus plain medium group (control); ▲▲▲p < 0.001 versus the HPV-16 E2 group, △△△p < 0.001
versus the HPV-16 E2 + gC1qR siRNA group.
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nign lesions) but may also regulate viral gene expression
(including the E6/E7 oncogenes) [18]. Our results dem-
onstrate that E2 transfection into HPV-negative C33A
cells or HPV-16-positive SiHa cells increased gC1qR ex-
pression, induced mitochondrial dysfunction, and en-
hanced apoptosis.
The gC1qR protein is primarily localised at the outer
mitochondrial membrane [19], enhances ROS produc-
tion and increases Ca2+ uptake by reducing the electron
flow from complex I [20]. In recent years, it has become
increasingly evident that gC1qR-induced mitochondrial
dysfunction is linked to apoptosis and the release of
cytotoxic factors such as ROS, which are generated in
excess in defective mitochondria. ROS induction, as a
by-product, can regulate signalling pathways leading to
the inhibition of cell proliferation or cell death [21]. Our
previous study demonstrated that gC1qR vector-treated
C33a and SiHa cells expressing gC1qR generated in-
creased levels of ROS. Oxidant generation correlated
with intracellular Ca2+ accumulation and a decrease in
the relative Δψm values, which in turn induced cell
apoptosis. However, treatment with metformin may re-
verse gC1qR-induced C33a and SiHa cell apoptosis. This
observation was also supported by the results derived
from the treatment that silenced the gC1qR gene in
HPV-16 E2-induced apoptosis.
Conclusion
This study has confirmed that E2 upregulates gC1qR gene
expression, which induces cervical cancer cell apoptosis.
We have also determined that the mechanism by whichgC1qR induces apoptosis is through mitochondrial dys-
function in human cervical squamous carcinoma cells.
Thus, gC1qR is a key player in the carcinogenesis of
HPV-induced cancer and is a potential target for cer-
vical cancer therapy.Additional files
Additional file 1: Figure S1. The biological effects of gC1qR over
expression on mitochondrial function of C33a and SiHa cells. A:
Constitutive expression of gC1qR induced the production of ROS in C33a
cells that were transfected with the empty vector or the gC1qR vector for
24, 36, 48, 60, 72, or 84 h. ROS generation was quantified by fluorescence
following treatment with H2DCFDA for 30 min and then subjected to
fluorescence microscopy. The data represent the mean ± SD. These
data are representative of three independent experiments. *p < 0.05,
**p < 0.01, ***p < 0.001, #p > 0.05 versus empty vector group. B: Constitutive
expression of gC1qR induced cellular calcium ion influx in the C33a and
SiHa cells. Quantitative estimation of the intracellular Ca2+ levels was
monitored using the Fluo-4 AM fluorescence probe in C33a and SiHa
cells at different time points ranging from 0 h to 84 h. All of the data are
representative of five independent experiments in which the data were
calculated by averaging the values as the mean ± SD. *p < 0.05, **p < 0.01,
***p < 0.001, #p > 0.05 versus empty vector group. C: The mitochondrial
membrane potential was observed. Time-dependent changes in the relative
Δψm value were observed, as detected by fluorescence of JC-1 (590: 527 nm).
These data are representative of three separate experiments. *p < 0.05,
**p < 0.01, ***p < 0.001, #p > 0.05 versus empty vector group.
Additional file 2: Figure S2. The effect of HPV-16 E2 on gC1qR
expression levels in cervical squamous carcinoma cell lines (C33a and
SiHa). Cells were treated with plain medium (control), empty vector,
HPV-16 E2 vector or HPV-16 E2 mutant vector for 48 h. A: The relative
gC1qR gene expression levels are shown in C33a and SiHa cells. gC1qR
expression levels were analysed by real-time PCR. ***p < 0.001, **p < 0.01,
#p > 0.05 versus the control group; ▲▲▲p < 0.001, ▲▲p < 0.01 versus the
empty vector group; △△△p < 0.001, △△p < 0.01 versus the HPV-16 E2 group.
B: gC1qR protein levels were measured in C33a and SiHa cells using western
blot analysis. The graph depicts the relative gC1qR protein levels normalised
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http://www.translational-medicine.com/content/12/1/286to actin. The results are expressed as the means ± SD of three separate
experiments. ***p < 0.001, #p > 0.05 versus the control group; ▲▲▲p < 0.001
versus the empty vector group; △△△p < 0.001 versus the HPV-16 E2
vector group
Additional file 3: Figure S3. The levels of gC1qR expression. C33a and
SiHa cells were treated with plain medium (control), negative siRNA, or
gC1qR siRNA for 48 h. The expression of the gC1qR protein was measured
by western blot analysis. The graph depicts the relative gC1qR protein levels
normalised to actin. The results are expressed as the mean ± SD of three
separate experiments. *p < 0.05, #p > 0.05 versus the plain medium group
Additional file 4: Figure S4. The effect of HPV-16 E2 on gC1qR
expression levels. Cells were treated with plain medium (control) or the
HPV-16 E2 vector. After 72 h, the cells were transfected with either 100
ng of the gC1qR siRNA vector or 100 ng of negative siRNA. A: Relative
gC1qR gene expression levels in the C33a and SiHa cervical squamous
carcinoma cell lines. gC1qR expression levels were analysed by real-time
PCR. ***p < 0.001, **p < 0.01, #p > 0.05 versus the HPV-16 E2 (-), gC1qR
siRNA (-) and negative siRNA (-) groups; ▲▲p < 0.01 versus the HPV-16
E2 (+), gC1qR siRNA (-) and negative siRNA (-) groups group; △△p < 0.01
versus the HPV-16 E2 (+), gC1qR siRNA (+) and negative siRNA (-) groups.
B: gC1qR protein levels were measured in C33a and SiHa cells using
western blot analysis. The graph depicts the relative gC1qR protein levels
normalised to actin. The results are expressed as the means ± SD of
three separate experiments. ***p < 0.001, **p < 0.01, #p > 0.05 versus
the HPV-16 E2 (-), gC1qR siRNA (-) and negative siRNA (-) groups;
▲▲▲p < 0.001, ▲▲p < 0.01 versus the HPV-16 E2 (+), gC1qR siRNA (-)
and negative siRNA (-) groups; △△△p < 0.001, △△p < 0.01 versus the
HPV-16 E2 (+), gC1qR siRNA (+) and negative siRNA (-) groups.
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